Literature DB >> 19199943

Tyrosine kinases and inflammatory signalling.

Theresa H Page1, Maria Smolinska, Justin Gillespie, Anna M Urbaniak, Brian M J Foxwell.   

Abstract

The activity of tyrosine kinases is central to many cellular processes, and accumulating evidence suggests that their role in inflammation is no less profound. Three main tyrosine kinase families, the Src, Tec and Syk kinase families are intimately involved in TLR signalling, the critical first step in cellular recognition of invading pathogens and tissue damage. Their activity results in changes in gene expression in affected cells. Key amongst these genes are the cytokines, which orchestrate both the duration and extent of inflammation. Tyrosine kinases also play important roles in cytokine function, and are implicated in signalling through both pro- and anti-inflammatory cytokines such as TNF, IL-6 and IL-10. Thus, strategies to modulate tyrosine kinase activity have significant therapeutic potential in combating the chronic inflammatory state that is typical of many major health issues that face us today, including Rheumatoid Arthritis, Cardiovascular disease and cancer. Here we review current knowledge of the role of tyrosine kinases in inflammation with particular emphasis on their role in TLR signalling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199943     DOI: 10.2174/156652409787314507

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  51 in total

Review 1.  Epigenetic mechanisms in inflammation.

Authors:  D Bayarsaihan
Journal:  J Dent Res       Date:  2011-01       Impact factor: 6.116

2.  Kinase activity profiling of gram-negative pneumonia.

Authors:  Arie J Hoogendijk; Sander H Diks; Maikel P Peppelenbosch; Tom Van Der Poll; Catharina W Wieland
Journal:  Mol Med       Date:  2011-03-15       Impact factor: 6.354

3.  Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.

Authors:  Yun Zhao; Carmen Alonso; Isabel Ballester; Joo Hye Song; Sun Young Chang; Bayasi Guleng; Seiji Arihiro; Peter J Murray; Ramnik Xavier; Koichi S Kobayashi; Hans-Christian Reinecker
Journal:  Inflamm Bowel Dis       Date:  2011-09-01       Impact factor: 5.325

4.  Bruton's tyrosine kinase mediates FcγRIIa/Toll-like receptor-4 receptor crosstalk in human neutrophils.

Authors:  Agnieszka Krupa; Rafal Fudala; Jon M Florence; Torry Tucker; Timothy C Allen; Theodore J Standiford; Rafal Luchowski; Marek Fol; Moshiur Rahman; Zygmunt Gryczynski; Ignacy Gryczynski; Anna K Kurdowska
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-13       Impact factor: 6.914

5.  The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines.

Authors:  Chong Yan; Chibo Liu; Qiaozhi Jin; Zhihai Li; Baohong Tao; Zhiyi Cai
Journal:  Oncol Lett       Date:  2012-06-19       Impact factor: 2.967

6.  Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion.

Authors:  Omer Nuri Pamuk; Peter H Lapchak; Poonam Rani; Polly Pine; Jurandir J Dalle Lucca; George C Tsokos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

7.  Src Family Kinases in Brain Edema After Acute Brain Injury.

Authors:  DaZhi Liu; Xiong Zhang; BeiLei Hu; Bradley P Ander
Journal:  Acta Neurochir Suppl       Date:  2016

8.  The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.

Authors:  M M Harnett; A J Melendez; W Harnett
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

9.  The Syk kinase SmTK4 of Schistosoma mansoni is involved in the regulation of spermatogenesis and oogenesis.

Authors:  Svenja Beckmann; Christin Buro; Colette Dissous; Jörg Hirzmann; Christoph G Grevelding
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

10.  Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis.

Authors:  Gautam Patel; Caitlin E Karver; Ranjan Behera; Paul J Guyett; Catherine Sullenberger; Peter Edwards; Norma E Roncal; Kojo Mensa-Wilmot; Michael P Pollastri
Journal:  J Med Chem       Date:  2013-05-03       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.